| Tag | Content |
|---|
EnhancerAtlas ID | HS060-20521 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr2:197153570-197154420 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| HES2 | MA0616.2 | chr2:197154144-197154154 | GGCACGTGCC | + | 6.02 | | HES2 | MA0616.2 | chr2:197154144-197154154 | GGCACGTGCC | - | 6.02 | | MEF2C | MA0497.1 | chr2:197153704-197153719 | TGGATAAAAATAGCA | + | 6.15 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_11133 | chr2:197152398-197158009 | CD20 | | SE_18248 | chr2:197153149-197154859 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_25416 | chr2:197153183-197154262 | DND41 | | SE_62200 | chr2:197013935-197160826 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I196288 | chr2 | 197153150 | 197154859 |
|
Enhancer Sequence | GAGAGGCAGG AGAAGAGCAC AGACTCTGGA GCTGGACTGC CTGGGTGCAA ATCCAATTCC 60
ACCACTTACG AATTGTGGGA CCTTGGTCAA TTCACGTAAT CATGCTGTGC CTCAGTTTCC 120
TCTTCTATAT AATGTGGATA AAAATAGCAC CCATCTCCAG GCTGCTGTGA GCACTAAATG 180
AACTAGTGTC TGGCCCAGGG GCAATGCTAC ATACTCCAGA ATACTACACT AAGTGGTAAA 240
TTTTTATCAT TGTTAGCACA ATGGTACACA CCTCAGAAGT GTTGCTGAAT GACTAAATAA 300
GTGAAAACAC GAAAGGAAGA TGTTACACTA GAGAAGAGGA GATGGAGGCA AATTTTAGCC 360
TGAGAACATT TCTGTTAAGA ACCATTTCCT TTCATGCAGA TGAGGATATG GACATCCTGT 420
TTCATATCAA CTCTAGAAAT CAGTCATCAC TGTGGGAAAA TAACTTCATA ATAGTTAATA 480
GCTTTGATGT TGCATTACAC GAAAAATGTT TTCTCCCTTC AAATGTTCTA GAAGCACAGC 540
AACTCATTTT TAAAAGGGTC AAGGCAGGCA GGGTGGCACG TGCCTATAGT TCCAGCTACT 600
TGGGAGGCTG AAGTGGGAGG ACTGCTTGAG CCCAGGAGTT CTGGACTACA GTGTGCTATG 660
CCAATCAGGT GTCCACACTA AGTTCCCCAA CAATATGGTG AACTCCGAGG AGTTGGAGAT 720
CACCAGGTTG CCTAAGGTAG GAGGAACCAG CCCAGGTTAG AAATGGCACA GGTTGAAACT 780
CCCATGCTGA TCAGTAGTGG GATCATATCT GTGAACAGCC ACTGTACTCC AGCCTGGGCA 840
ACATAGCAAG 850
|
